Riyadh – Mubasher: Dallah Healthcare Company generated SAR 84.52 million in net profit attributable to the shareholders during the first quarter (Q1) of 2026, an annual drop of 45.66% from SAR 155.56 million.
The revenues grew by 21.67% to SAR 1.01 billion in Q1-26 from SAR 832.75 million in the year-ago period, according to the interim financial results.
On the other hand, the earnings per share (EPS) fell to SAR 0.84 as of 31 March 2026 from SAR 1.59 in Q1-25.
Quarterly, the net profits plunged by 27.47% from SAR 116.54 million in Q4-25, while the revenues declined by 8.75% from SAR 1.11 billion.
Dividends
The medical group announced cash dividends valued at SAR 50.48 million, representing 5% of its capital, to 100.96 million eligible shares for Q1-26.
Eligibility and payment dates for the SAR 0.50/share dividend will be 17 May and 4 June, respectively.
Dallah Healthcare closed 2025 with 14.23% YoY higher net profits at SAR 538.27 million.
